Who are Prothea Technologies's investors?

Prothea Technologies's investors include Korys, Mérieux Equity Partners, Earlybird Venture Capital, Old College Capital.

Prothea Technologies

6 known investors

prothea.tech ↗

Prothea is developing technology to combine lung cancer biopsy and treatment into a single hospital visit, reducing the time from diagnosis to treatment. It aims to ease hospital workloads and improve patient outcomes.

BiotechHealthtechMedical Devices

Investors · 6

KorysHalle · $5.4M

Mérieux Equity PartnersParis · $3.2M – $86M

Earlybird Venture Capitalreported · 2 sourcesBerlin · $540K – $12M

Old College Capitalreported · 2 sourcesEdinburgh · $190.5K

Also in the syndicate · 2

Merieux Equity PartnersleadNRW.BANK

Funding

SEC filings, press & company announcements

Undisclosed amountSeries AApr 2025
Earlybird Venture Capital (lead), Merieux Equity Partners (lead), NRW.BANK, Old College Capital
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Prothea Technologies Launches with €12M Series A to Innovate Lung Cancer Diagnosis and Treatment. - Prothea Technologiesprothea.tech · Apr 2025

Prothea Technologies in a €12M Series A co-led by Earlybird Venture Capital and Merieux Equity Partners, joined by NRW.BANK and Old College Capital | Nordic 9nordic9.com

Frequently asked questions

What does Prothea Technologies do?: Prothea is developing technology to combine lung cancer biopsy and treatment into a single hospital visit, reducing the time from diagnosis to treatment. It aims to ease hospital workloads and improve patient outcomes.
Who are Prothea Technologies's investors?: Prothea Technologies's investors include Korys, Mérieux Equity Partners, Earlybird Venture Capital, Old College Capital.